The CEO of Bioviva USA Inc., Elizabeth Parrish, became the first person to undergo rejuvenative gene therapy in 2015, and results are now out – the procedure successfully lengthened her telomeres by the equivalent of 20 years.

- PhD student researching Aging, Mitochondria, and Regenerative Medicine -
I currently write for The Conversation (http://bit.ly/13WVyUW) and I have
written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford
University Scientific Society - Co-conspirator at the Oxford Transhumanism
and Emerging Technologies - Designing exciting events with the British
Science Association Oxford - Advisory Board member at Lifeboat Foundation's
Life Extension Board, and the Sustainability Board - Also, I am an Ultimate
(frisbee) enthusiast - Yes, unfortunately that's me trying to catch the
frisbee